Androgen suppression combined with elective nodal irradiation and dose escalated prostate treatment: A non-inferiority, phase III randomized controlled trial of stereotactic body radiation therapy versus brachytherapy boost in patients with unfavourable risk localized prostate cancer (ASCENDE-SBRT; CCTG PR24; NCT06235697).

Authors: Andrew Loblaw, Rachel Glicksman, Joelle Antoine Helou, Winkle Kwan, Gerard Morton, Tamim Niazi, Melanie Davidson, M. Neil Reaume, Alexander William Wyatt, Constance Laroche-Lefebvre, Keyue Ding, Wendy R. Parulekar

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps5132

Source: Full article

---

Abstract

TPS5132